...
首页> 外文期刊>International journal of colorectal disease. >GSTM1 and GSTT1 polymorphisms and colorectal cancer risk in Chinese population: A meta-analysis
【24h】

GSTM1 and GSTT1 polymorphisms and colorectal cancer risk in Chinese population: A meta-analysis

机译:GSTM1和GSTT1基因多态性与中国人群结直肠癌风险的荟萃分析

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Purpose Studies investigating the associations between GSTM1 and GSTT1 polymorphisms and colorectal cancer (CRC) risk in Chinese population have reported controversial results. Thus, a meta-analysis was performed. Methods Four hundred and seven relevant records were identified through a literature search up to September 7, 2011, and 19 studies were finally included, involving a total of 3,130 CRC cases and 6,423 controls. Subgroup analyses were performed by language and study design. Statistical analysis was performed with the software programs Review Manager (version 5.1.2) and STATA (version 11.0). Results For the GSTM1 polymorphism, the null genotype of GSTM1 was not associated with CRC risk in Chinese population (OR=1.12, 95% CI=0.97-1.28). Similar associations were found for GSTT1 polymorphism (OR=1.10, 95% CI=0.94-1.29) and the dual null genotype of GSTM1/GSTT1 (OR=1.26, 95% CI=0.93-1.71). For subgroup analyses, studies published in English and population-based studies further identified these associations for the three aspects above in Chinese population. Conclusions This meta-analysis suggests that the null genotypes of GSTM1 and GSTT1 and the dual null genotype of GSTM1/GSTT1 were all not risk factors in CRC in Chinese population.
机译:目的研究中国人群中GSTM1和GSTT1多态性与结直肠癌(CRC)风险之间的关系的研究报告了有争议的结果。因此,进行了荟萃分析。方法截至2011年9月7日,通过文献检索共鉴定407条相关记录,最终纳入19项研究,涉及3,130例CRC病例和6,423例对照。通过语言和研究设计进行亚组分析。使用软件程序Review Manager(版本5.1.2)和STATA(版本11.0)进行统计分析。结果对于GSTM1多态性,GSTM1的无效基因型与中国人群的CRC风险无关(OR = 1.12,95%CI = 0.97-1.28)。对于GSTT1多态性(OR = 1.10,95%CI = 0.94-1.29)和GSTM1 / GSTT1的双重无效基因型(OR = 1.26,95%CI = 0.93-1.71)也发现了相似的关联。对于亚组分析,以英语发表的研究和基于人群的研究进一步确定了上述与中国人口三个方面相关的联系。结论这项荟萃分析表明,GSTM1和GSTT1的无效基因型和GSTM1 / GSTT1的双重无效基因型均不是中国人群CRC的危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号